{
    "nctId": "NCT02234479",
    "briefTitle": "MediHoney for Radiation Dermatitis",
    "officialTitle": "A Pilot Study: Topical Application of Medihoney for Management of Radiation Dermatitis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Radiation Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 34,
    "primaryOutcomeMeasure": "Number of Participants Whom Received Medihoney Treatment and Were Analyzed Weekly for Skin Changes While Undergoing Radiation Therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer treated with either lumpectomy or mastectomy (with or without reconstruction).\n* The patient must be female.\n* Radiation therapy planned to whole breast/chestwall area (can include lymph node radiation; conventional 3D radiation, IMRT/IGRT, and hypofractionation are all allowed).\n* Age \u2265 18 years old.\n\nExclusion Criteria:\n\n* Previous radiation therapy to chest area that would result in overlapping radiation fields.\n* Wound care issues.\n* Patients undergoing concurrent cytotoxic chemotherapy and radiation therapy (concurrent Herceptin and/or tamoxifen/aromatase inhibitors and RT is allowed).\n* Patients receiving HDR (savi or mammosite) brachytherapy treatments.\n* Patients with an allergy and/or sensitivity to Hydrophor, honey, and/or Medihoney.\n* Immunocompromised status.\n* Age \\< 18 years old.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}